5:59 PM
 | 
Oct 25, 2012
 |  BC Extra  |  Financial News

Biogen Idec beats Street

Biogen Idec Inc. (NASDAQ:BIIB) reported 3Q12 non-GAAP diluted EPS of $1.91, beating the Street's $1.59 estimate by $0.32 and up 19% from $1.61 in 3Q11. Third quarter revenues were $1.39 billion, slightly above the Street's...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >